Scores of people experience complications after change from Tysabri to Tyruko as part of NHS drive to save money
‘It was awful for me’: one MS patient shares her experience with Tyruko
Scores of people with multiple sclerosis (MS) have suffered debilitating side-effects after being put on to a cheaper new drug as part of an NHS drive to save money.
About 170 MS patients at Charing Cross hospital in London have had complications, including a relapse of their illness, after being switched from Tysabri to a different drug called Tyruko, made by the pharmaceutical company Sandoz.
About Author
More Stories
I became absorbed in strangers’ fertility journeys online
Microsoft unveils chip it says could bring quantum computing within years
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’